HCA Healthcare and Grail team on multi-cancer early detection screening

HCA Healthcare Sarah Cannon Cancer Institute, part of HCA Healthcare, and GRAIL , a healthcare company with a mission of detecting cancer early when it can be cured announced a strategic collaboration to advance comprehensive cancer care through early detection. Starting today, GRAIL’s Galleri multi-cancer early detection MCED test will be available to patients who meet screening criteria at select HCA Healthcare physician practices…”HCA Healthcare and Sarah Cannon are aligned with GRAIL’s mission to improve the detection of cancer at earlier stages, when the chances of successful treatment are higher,” said Jeffrey Venstrom, MD, chief medical officer at GRAIL. “In addition to HCA Healthcare offering the Galleri test, the use of Sarah Cannon Cancer Institute’s nurse navigation program to support both patients and healthcare providers around MCED screening is the first of its kind. This program will provide critical insights about cancer detection and appropriate diagnostic follow-up.”